Is There a Place for Placebo in Management of Psychogenic
... handing a patient an inert substance purporting to be an active agent in order to treat an organic disease is ethically unconscionable. Some would go so far as to say that any practice that involves the deceiving of patients is inappropriate.8 This would then render unethical practices such as admin ...
... handing a patient an inert substance purporting to be an active agent in order to treat an organic disease is ethically unconscionable. Some would go so far as to say that any practice that involves the deceiving of patients is inappropriate.8 This would then render unethical practices such as admin ...
the first US FDA approved biological therapy for systemic lupus
... Supported by randomized controlled trials, belimumab is confirmed to be effective in reducing SLE disease activity on top of background immunosuppressive therapy and delaying the time to lupus flares. The drug is well tolerated in SLE patients up to 5 years. Serious infections and malignancy are no ...
... Supported by randomized controlled trials, belimumab is confirmed to be effective in reducing SLE disease activity on top of background immunosuppressive therapy and delaying the time to lupus flares. The drug is well tolerated in SLE patients up to 5 years. Serious infections and malignancy are no ...
Susceptibility to nontuberculous mycobacterial lung disease REVIEW P. Sexton and A.C. Harrison
... bronchiectasis, cystic fibrosis (CF), previous TB, silicosis, pneumoconiosis and alveolar proteinosis [21–30]. Other established risk factors for NTMLD include increasing age, male sex, smoking, alcohol abuse, residence in urban or coastal environments, and participation in mining and smelting [31]. ...
... bronchiectasis, cystic fibrosis (CF), previous TB, silicosis, pneumoconiosis and alveolar proteinosis [21–30]. Other established risk factors for NTMLD include increasing age, male sex, smoking, alcohol abuse, residence in urban or coastal environments, and participation in mining and smelting [31]. ...
Applying openEHR and GDL for streamlining
... diseases that present particular challenges for health care information management. It is not clinically obvious, it depends on information from relatives, and has frequently been underdiagnosed. There was a perceived need for an investigation of how modern informatics tools such as openEHR and GDL ...
... diseases that present particular challenges for health care information management. It is not clinically obvious, it depends on information from relatives, and has frequently been underdiagnosed. There was a perceived need for an investigation of how modern informatics tools such as openEHR and GDL ...
Conservative treatment options for carpal tunnel syndrome: a
... laterally treated, number of patients or hands randomised), interventions (type, treatment schedule), outcome measures, timing of the follow-up measurements, and results (point estimates and measures of variability, number of patients or hands). Although data on all reported outcomes were extracted, ...
... laterally treated, number of patients or hands randomised), interventions (type, treatment schedule), outcome measures, timing of the follow-up measurements, and results (point estimates and measures of variability, number of patients or hands). Although data on all reported outcomes were extracted, ...
Comer, Abnormal Psychology, 8th edition
... There are no dietary restrictions like there are with MAO inhibitors They have fewer side effects than the tricyclics ...
... There are no dietary restrictions like there are with MAO inhibitors They have fewer side effects than the tricyclics ...
Role of monoclonal antibodies in the treatment of immune
... excretion to normal range, and 20 of the 35 who failed to achieve remission had their proteinuria reduced to less than 50% of baseline values. Treatment effect was time-dependent and all patients with at least four years of follow-up achieved complete or partial remission (Figure 1). Rituximab was e ...
... excretion to normal range, and 20 of the 35 who failed to achieve remission had their proteinuria reduced to less than 50% of baseline values. Treatment effect was time-dependent and all patients with at least four years of follow-up achieved complete or partial remission (Figure 1). Rituximab was e ...
The Diagnosis, Staging, and Treatment Options for Mycosis Fungoides
... to 60 years). Children and adolescents are rarely affected. Approximately 1,000 new cases are diagnosed each year in the United States.12 The course of MF is usually indolent, with slow progression over years to decades, but it can be unpredictable. It usually demonstrates epidermotropism by involvi ...
... to 60 years). Children and adolescents are rarely affected. Approximately 1,000 new cases are diagnosed each year in the United States.12 The course of MF is usually indolent, with slow progression over years to decades, but it can be unpredictable. It usually demonstrates epidermotropism by involvi ...
Cancer Institute NEWSLETTER
... senior group leader at the Marie Curie Research Institute (Oxted, Surrey). He did his post doctoral fellowship with Nobel Prize winner, Sir Tim Hunt. Professor Yamano’s Group studies the basic principles of how cells divide and proliferate. Uncontrolled cell division is a key characteristic of cance ...
... senior group leader at the Marie Curie Research Institute (Oxted, Surrey). He did his post doctoral fellowship with Nobel Prize winner, Sir Tim Hunt. Professor Yamano’s Group studies the basic principles of how cells divide and proliferate. Uncontrolled cell division is a key characteristic of cance ...
RADIATION THERAPY ONCOLOGY GROUP RTOG 0418 A Phase II
... Unfortunately, conventional WPRT results in the irradiation of large volumes of small bowel, rectum and bladder. Conventional techniques used to treat the pelvis with radiation therapy after hysterectomy for carcinoma of the uterine cervix or corpus involve either two (AP-PA) or four (AP, PA, Right ...
... Unfortunately, conventional WPRT results in the irradiation of large volumes of small bowel, rectum and bladder. Conventional techniques used to treat the pelvis with radiation therapy after hysterectomy for carcinoma of the uterine cervix or corpus involve either two (AP-PA) or four (AP, PA, Right ...
Document
... crease of brain inflammation in this patient (91 contrast-enhancing lesions; Fig. 3). Such MRI activwith a negative value of –2 or less, and was stable between –1 and +1 ity was very atypical for this patient, who had been monitored (Table 1). As T cells specific for APL were induced in all patients ...
... crease of brain inflammation in this patient (91 contrast-enhancing lesions; Fig. 3). Such MRI activwith a negative value of –2 or less, and was stable between –1 and +1 ity was very atypical for this patient, who had been monitored (Table 1). As T cells specific for APL were induced in all patients ...
Cutaneous Vascular Diseases, Part 1
... Mondor’s Disease Cause is multifactorial Incidence L=R No systemic symptoms associated Treatment of the symptom: hot moist dressing and NSAID Runs its course for 3-6 months. ...
... Mondor’s Disease Cause is multifactorial Incidence L=R No systemic symptoms associated Treatment of the symptom: hot moist dressing and NSAID Runs its course for 3-6 months. ...
GHTF SG5 Clinical Performance Studies for IVD Medical Devices
... Clinical performance studies should be designed in such a way as to maximize the relevance of the data while minimizing potential biases. Designs of IVD medical device clinical performance studies are either observational or interventional. An observational study refers to a study in which test resu ...
... Clinical performance studies should be designed in such a way as to maximize the relevance of the data while minimizing potential biases. Designs of IVD medical device clinical performance studies are either observational or interventional. An observational study refers to a study in which test resu ...
Personalised medicine in exacerbations of COPD: the beginnings EDITORIAL Sanjay Sethi
... as a determinant of antibiotic treatment in hospitalised exacerbations of COPD. The design of this study is unique in that antibiotics were withheld in patients without purulent sputum and the comparator group was composed of patients with purulent exacerbations treated with antibiotics. Of note, on ...
... as a determinant of antibiotic treatment in hospitalised exacerbations of COPD. The design of this study is unique in that antibiotics were withheld in patients without purulent sputum and the comparator group was composed of patients with purulent exacerbations treated with antibiotics. Of note, on ...
Project Grant Application
... determined by evaluation of the RA core set or indices derived thereof.(1-2) The core set contains the patient reported outcomes (PROs) physical function, pain and global assessment of disease activity. Although not consistently associated with joint damage and differential response in disease stage ...
... determined by evaluation of the RA core set or indices derived thereof.(1-2) The core set contains the patient reported outcomes (PROs) physical function, pain and global assessment of disease activity. Although not consistently associated with joint damage and differential response in disease stage ...
Canine Hyperadrenocorticism (HAC, Cushing`s disease)
... months of therapy, requiring a repeat of the loading phase and higher maintenance dosages. Rechecks include one to three ACTH stimulation tests during the loading phase, followed by periodic tests thereafter (usually once every 4 months or so). Trilostane is a newer drug that has been used in Eur ...
... months of therapy, requiring a repeat of the loading phase and higher maintenance dosages. Rechecks include one to three ACTH stimulation tests during the loading phase, followed by periodic tests thereafter (usually once every 4 months or so). Trilostane is a newer drug that has been used in Eur ...
Poultry Campylobacter
... to Exposed People Mode of Transmission Incubation Period Clinical SignsHuman Clinical SignsAnimal Control and Prevention Comments ...
... to Exposed People Mode of Transmission Incubation Period Clinical SignsHuman Clinical SignsAnimal Control and Prevention Comments ...
creatine kinase-mb - The Professional Medical Journal
... the first study of comparing the levels of CKMB in male and female acute myocardial infarct patients before and after the treatment. The levels of CK-MB before treatment was high in male as compared to female patients. Similarly comparison of CK-MB levels after 24 and 48 hours of treatment were also ...
... the first study of comparing the levels of CKMB in male and female acute myocardial infarct patients before and after the treatment. The levels of CK-MB before treatment was high in male as compared to female patients. Similarly comparison of CK-MB levels after 24 and 48 hours of treatment were also ...
Alzheimer`s Disease of the Immune System A New Variant of
... to various pathogens can determine the latency status, the immune response, and in some cases oncogenic ability. Immune response to DosR and Rpf antigens from Mycobacterium tuberculosis (Mtb) seems to be important for latency maintenance [28]. Here we present 3 case reports of patients who presented ...
... to various pathogens can determine the latency status, the immune response, and in some cases oncogenic ability. Immune response to DosR and Rpf antigens from Mycobacterium tuberculosis (Mtb) seems to be important for latency maintenance [28]. Here we present 3 case reports of patients who presented ...
10_2007
... Convert from IV to oral breakthrough using po MS or oxycodone in 1-2 days Discharge when stable and improving on SRMS or SR-oxycodone ...
... Convert from IV to oral breakthrough using po MS or oxycodone in 1-2 days Discharge when stable and improving on SRMS or SR-oxycodone ...
Da Volterra presents new data supporting DAV132 as a promising
... while maintaining the efficacy of the antibiotic treatment. As a consequence the flora disruption adverse effect is avoided. ...
... while maintaining the efficacy of the antibiotic treatment. As a consequence the flora disruption adverse effect is avoided. ...
Ophthalmic drug discovery: novel targets and
... mice. Genetically modified mice are the only animal models developed to date that recapitulate the features of both dry and wet AMD35–40. Ranibizumab (Lucentis; Genentech/Roche), bevacizumab (Avastin; Genentech/Roche) and aflibercept (Eylea; Regeneron Pharmaceuticals) — all anti-VEGF agents — are cu ...
... mice. Genetically modified mice are the only animal models developed to date that recapitulate the features of both dry and wet AMD35–40. Ranibizumab (Lucentis; Genentech/Roche), bevacizumab (Avastin; Genentech/Roche) and aflibercept (Eylea; Regeneron Pharmaceuticals) — all anti-VEGF agents — are cu ...
